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Earlier studies from this laboratory showed that human folylpolyglutamate synthetase (FPGS) exists as cytosolic and mitochondrial (mFPGS)
isoforms. Localization of mFPGS within mitochondria may help elucidate how the enzyme functions to maintain the mitochondrial folate pool. A
human T-lymphoblastic leukemia CCRF-CEM cell lysate was fractionated by differential centrifugation into cytosolic and mitochondrial fractions.
Activity assays for cytosol-and mitochondria-specific enzymes verified the purity and integrity of the fractions. Mitochondria were subfractionated
with increasing concentrations of digitonin to successively extract the four submitochondrial compartments. Western analyses of the fractions
using protein markers specific for each compartment suggest that mFPGS is distributed in the matrix and/or inner membrane compartments.
Further support for an interaction of mFPGS with the inner mitochondrial membrane is provided by localization of about half of the mFPGS in the
mitochondrial membrane fraction obtained by freeze–thaw of intact mitochondria; the remaining mFPGS is located in the soluble fraction.
Resistance of about half of the mFPGS in whole mitochondria to alkaline carbonate extraction suggests that its interaction with the inner
membrane is more similar to an integral, than a peripheral, membrane protein. The data suggest that human mFPGS is at least in part strongly
associated with the inner mitochondrial membrane.
D 2005 Elsevier B.V. All rights reserved.Keywords: Folylpolyglutamate synthetase; Polyglutamate; Mitochondria; Folate; Leukemia; CCRF-CEM0167-4889/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2005.08.004
Abbreviations: ADP, adenosine 5V-diphosphate; ATP, adenosine 5V-triphos-
phate; BSA, bovine serum albumin; cFPGS, cytosolic FPGS; COX IV,
cytochrome c oxidase subunit IV (EC 1.9.3.1); CSPD, disodium 3-(4-
methoxyspiro{1,2-dioxetane-3,2V-[5V-chloro]tricyclo[3.3.1.13,7]decan}-4-
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ethylenediaminetetraacetic acid; FPGS, folylpolyglutamate synthetase (EC
6.3.2.17); GDH, glutamate dehydrogenase (EC 1.4.1.3); HEPES, 1-piperazi-
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sucrose, 220 mM mannitol, 2 mM HEPES adjusted to pH 7.4 with KOH and
made up to 0.16 mg/ml in benzamidine-HCl, 0.5 mM in Pefabloc, and 0.5 mg/
ml in protease-free BSA; IM, inner mitochondrial membrane; IMS, intermem-
brane space; LDH, lactate dehydrogenase (EC 1.1.1.27); mFPGS, mitochon-
drial FPGS; MnSOD, manganese superoxide dismutase (EC 1.15.1.1); NADH,
nicotinamide adenine dinucleotide (reduced); OM, outer mitochondrial
membrane; PBS, phosphate buffered saline; PCR, polymerase chain reaction;
PNS, postnuclear supernatant; PVDF, polyvinylidene difluoride; SDS-PAGE,
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dependent anion channel protein (SwissProt P21796)
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Folylpolyglutamate synthetase (FPGS) catalyzes the ATP-
dependent addition of glutamate residues to the g-carboxyl of
folates to synthesize folylpoly(g-glutamates) [1], which are the
predominant folates in cells. Mammalian cells utilize folylpo-
lyglutamates as more efficient substrates for most of the folate-
dependent enzymes that are involved in the one-carbon transfer
reactions involved in purine, pyrimidine and amino acid
synthesis. Folylpolyglutamates also aid in intracellular reten-
tion of folates at concentrations much higher than that in the
extracellular milieu. Both of these functions are required for
cell viability and thus FPGS is an essential enzyme [2]. FPGS
exists as cytosolic (cFPGS) and mitochondrial (mFPGS)
isoforms [3] that are transcribed from one nuclear gene as
two classes of mRNAs [4–6]. One class codes only for cFPGS,
while the second class has two different in-frame translational
start sites, one of which also encodes cFPGS, while theta 1746 (2005) 38 – 44
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43 amino acids at the N-terminal that have the characteristics of
a mitochondrial signal sequence. Studies of the regulation of
transcription and translation of these mRNAs are ongoing.
cFPGS and mFPGS maintain folylpolyglutamate pools in the
cytosol and mitochondria, respectively. Studies by Lin and
Shane [7] have shown, however, that mitochondrial folylpo-
lyglutamates may exit to the cytosol at a slow rate and allow for
cell viability in the absence of cFPGS. Thus, mFPGS may play
a critical role in maintaining cellular folate homeostasis.
We have undertaken to determine the submitochondrial
location of mFPGS because its location may influence its
physiological function. Digitonin fractionation [8] of isolated
mitochondria was used to sequentially release the protein
contents of the outer membrane, intermembrane space, inner
membrane, and matrix. Because the results indicated that up to
50% of the mFPGS might be associated with the inner
membrane, we used freeze–thaw [9] and alkaline carbonate
extraction procedures [10] to verify its submitochondrial
location and to study the nature of the association of mFPGS
with the inner membrane.
2. Materials and methods
2.1. Materials
Digitonin (ultrapure) and benzamidine–HCl were purchased from Calbio-
chem, La Jolla, CA. a-Ketoglutaric acid (Na2 salt), Na-pyruvate, ADP, and
Pefabloc SC were from Sigma Chemical Co. (St. Louis, MO), Nutritional
Biochemicals Corp. (Cleveland, OH), USB Corp. (Cleveland, OH), and
Centerchem Inc. (Stamford, CT), respectively. NADH (Na2 salt) and CSPD
were from Roche Biochemicals (Indianapolis, IN). Immobilon-P polyvinyli-
dene difluoride (PVDF, Millipore) membrane was obtained from Fisher
Scientific (Pittsburgh, PA). All other chemicals were of the highest grade
available.
2.2. Protein determination
Protein concentration was determined by the Bradford assay [11] using a
BioRad (Hercules, CA) protein assay kit. All readings were corrected for
interference from buffer components.
2.3. Cell culture
The CCRF-CEM human T-lymphoblastic cell line was cultured as
described [12]; it was periodically screened for mycoplasma contamination
using Stratagene Mycoplasma Plusi PCR primers (La Jolla, CA) and was
confirmed negative. Cell numbers were quantitated using a Coulter model Z1
counter (Beckman Instruments; Fullerton, CA) with a 140-A aperture.
2.4. Isolation and characterization of human cytosolic and
mitochondrial fractions
Subcellular fractionation of CCRF-CEM extracts into cytosolic and
mitochondrial fractions was performed essentially as described [3]. Postnuclear
supernatant (PNS), cytosol and mitochondrial fractions were assayed for
activity of the cytosolic enzyme lactate dehydrogenase (LDH) [13] and
mitochondrial matrix enzyme glutamate dehydrogenase (GDH) [14] to verify
purity, yield and integrity of the mitochondrial fraction. Assays were performed
in quartz cuvettes at 340 nm using a Gilford 240 spectrophotometer over a 3- to
4-min time period at 25 -C. All values reported are the average of two sample
dilutions assayed in duplicate to verify enzyme linearity. LDH assays (1 ml)contained 120 mM Tris–HCl (pH 7.3), 0.2 mM Na2-NADH and 250 mM
sucrose and were initiated by addition of Na-pyruvate to a final concentration
of 0.9 mM. GDH assays (1 ml) contained 100 mM imidazole (pH 7.9), 220 mM
ammonium acetate, 0.2 mM Na2-NADH, 0.9 mM Na2-EDTA (pH 7.5), 1.7 mM
Na2-ADP and 250 mM sucrose and were initiated by addition of a-
ketoglutarate to a final concentration of 14 mM. GDH activity was measured
in the presence and absence of 0.1% (v/v) Triton X-100 to assess mitochondrial
integrity (latency). Latency was calculated as a percent ratio of the difference in
GDH activity with and without Triton X-100 to the GDH activity with Triton
X-100. Mixing of the cytosolic fraction with the mitochondrial fraction yielded
97% and 100% of the expected LDH and GDH activity, respectively (n =2).
2.5. Submitochondrial fractionation with digitonin
All procedures were performed at 4 -C. The mitochondrial pellet (above)
was suspended in H-medium (70 mM sucrose, 220 mM mannitol, and 2 mM
HEPES, all adjusted to pH 7.4 with KOH, and made up to 0.16 mg/ml in
benzamidine–HCl, 0.5 mM in Pefabloc, and 0.5 mg/ml in protease-free BSA)
[15] to a final protein concentration of 10 mg/ml. The mitochondrial suspension
was divided into 8 fractions and digitonin [16] (from a stock of 1.6% (w/v) in
H-medium) was added to a final concentration of 0–0.7% (w/v) in increments
of 0.1% (w/v) [8]. Samples were incubated for exactly 1 min on ice, quickly
diluted with 4 volumes of ice-cold H-medium, and centrifuged at 48,000g for
20 min at 4 -C in a Beckman SW-55Ti swinging bucket rotor. The supernatant
was saved separately. Pellets were suspended in 1/4th supernatant volume of H-
medium and vortexed and sonicated for 30 s in a Branson-1200 sonic water
bath (Branson, Danbury, CT) at the maximum setting to homogenize the
suspension. Pellet suspensions were assayed by quantitative Western analysis
(below) for release of marker proteins for each mitochondrial subcompartment
and for mFPGS.
2.6. Freeze– thaw fractionation of mitochondria
The mitochondrial suspension in isotonic buffer [4] from the subcellular
fractionation procedure was centrifuged at 10,000gmax for 15 min at 4 -C in a
Beckman-Coulter microfuge 22 R and the supernatant was discarded. The
mitochondrial pellet was suspended to its original volume in 50 mM Tris–HCl,
pH 7.5, 0.5 mM Na2-EDTA, pH 7.5, 0.5 mM Pefabloc, and 1 mM benzamidine
and lysed by freezing for 5 min in liquid N2 and then thawing rapidly by
warming between the fingertips just until the last ice melted. The freeze– thaw
was performed 4 times. The suspension was centrifuged at 144,000gav at 4 -C
for 1 h in a Beckman TLA100 tabletop micro-ultracentrifuge using the
TLA100.3 rotor. The supernatant was removed and the pellet was resuspended
in the original volume of the same buffer, freeze– thawed four times as
described above, and centrifuged as above. Both supernatants were pooled and
used as the soluble fraction. The pellet was resuspended in isotonic buffer and
used as the membrane fraction. Soluble and membrane fractions were assayed
by quantitative Western analysis (below) for the presence of mFPGS and
protein markers.
2.7. Alkaline carbonate extraction of intact mitochondria
Alkaline carbonate extraction of intact mitochondria was performed as
described [10]. Briefly, a mitochondrial suspension in isotonic buffer was
treated with an equal volume of ice-cold 200 mM Na2CO3, pH 11.5 containing
0.5 mM Pefabloc and mixed by tapping and vortexing to a final concentration
of 100 mM Na2CO3. Mitochondria similarly treated with an equal volume of
266 mM NaCl containing 0.5 mM Pefabloc to a final concentration of 133 mM
NaCl (experimentally determined to be equivalent in ionic strength to 100 mM
Na2CO3) were maintained as a control. Both treatments were incubated on ice
for 30 min. The samples were centrifuged at 144,000gav at 4-C for 1 h in a
Beckman TLA100 tabletop micro-ultracentrifuge using the TLA100.3 rotor.
The pellets were resuspended to their original volume (before Na2CO3
addition) in 100 mM Na2CO3, pH 11.5, 0.5 mM Pefabloc or 133 mM NaCl,
0.5 mM Pefabloc, respectively, incubated on ice again for 30 min, and
centrifuged as above. Pellets were suspended in isotonic buffer to yield the
membrane fraction, while the supernatants from both the extractions were
Table 1
Estimation of mitochondrial purity, yield and content of subcellular fractions
from CCRF-CEM cells










PNS 240T50 1.00 4.4T0.7 (0.1T0.1)b 1.00
Cytosol 200T15 1.12 0.0 0.00
Mitochondria 3.9T0.4 0.09 3.0T0.4 (0.25T0.07)b 3.90
CCRF-CEM cells were cultured and fractionated as described under Materials
and methods. Lactate dehydrogenase (LDH) and glutamate dehydrogenase
(GDH) activities were measured as described in Materials and methods. All
values are averageTS.D. of two sample dilutions assayed in duplicate (n =4).
The entire experiment was performed twice with similar results.
a Relative specific activity is the specific activity of cytosol or mitochondria
relative to that of PNS (2.0 and 0.036 Amol/min/mg protein for LDH and GDH,
respectively).
b Values in parenthesis represent GDH activity of fractions in the absence of
Triton X-100, to determine latency.
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Western analysis as described below.
2.8. Western analysis of mitochondrial markers and mFPGS
2.8.1. SDS-PAGE, Western transfer, and immunodetection
Samples were electrophoresed with cooling at 150 V (constant) using 15-
well 7% (FPGS) or 15% (other proteins) SDS-PAGE separating gels (8.5 cm
W5.5 cm H0.75 cm thick) with a 0.5 cm 4% stacking gels, using Mini-
Protean II units (Bio-Rad) and standard buffer conditions. Western blotting was
performed at 25 V (constant) at room temperature for 3 h. Protein blow-through
and incomplete transfer out of the gel were examined as described [3]. Primary
PVDF membranes were blocked with 1% (w/v) casein in PBS-T (PBS+ 0.1%
Tween-20) for 1 h and then treated with appropriate dilutions of antibodies
against the markers of mitochondrial compartments: outer membrane, voltage-
dependent anion channel protein (VDAC; 31 kDa; Calbiochem, La Jolla, CA);
intermembrane space, cytochrome c (cytC; ¨13 kDa; Zymed Laboratories Inc.,
San Francisco, CA); inner membrane, cytochrome c oxidase subunit IV (COX
IV; ¨15 kDa; Molecular Probes, Eugene, OR); and matrix, manganese
superoxide dismutase (MnSOD; 25 kDa; Stressgen Biotechnologies, Victoria,
Canada). Western transfer and immunoblotting for the detection of FPGS (¨60
kDa) with a rabbit polyclonal antibody were performed as described [3], except
that blocking was performed with 1% (w/v) casein in PBS-T. Western blots
were treated with CSPD chemiluminescent substrate and exposed to Kodak
BioMax X-ray films. Cell equivalents used in blots and exposure times were
predetermined to lie within the linear range of the film. Bands were quantitated
as described below. All experiments were performed twice.
2.8.2. Standardization of strategy for densitometric protein quantitation
Western transfer conditions were systematically investigated and a transfer
buffer containing 25 mM Tris base, 192 mM glycine, 20% methanol and 0.05%
SDS gave very reproducible transfer patterns on PVDF membranes from
multiple gels for each of the four mitochondrial markers; consistently, however,
there was progressively more transfer/retention of proteins towards the sides of
the blots than in the center. A loading strategy was devised to compensate for
this effect. As an example, analysis of the 0–0.7% digitonin fractionation
fractions (above), which requires five SDS-PAGE gels per complete analysis, is
presented. Gels 1–3 were loaded with 0–0.5% digitonin samples, while gels
4–5 were loaded with 0% and 0.6–0.7% digitonin samples. Gels 1–3 were
divided virtually into two halves with lanes 3–8 (half-1) representing
progressively decreasing signal and lanes 9–14 (half-2) representing progres-
sively increasing signal on the corresponding Western blot. Lane 1 always
contained Bio-Rad Unstained Precision Protein Standards, while lanes 2 and 15
contained only a volume of 1 Laemmli sample buffer [17] equal to that of the
experimental samples. The fraction to which all other samples were normalized,
in this case 0% digitonin, was always in lanes 3 and 9. In gels 1–3, lanes 4 and
10, 5 and 11, 6 and 12, 7 and 13, and 8 and 14 were loaded with duplicates of
five samples. Gel 1 contained all samples at 1 cell equivalents, gel 2
contained all samples at 2 cell equivalents, and gel 3 contained all samples at
3 cell equivalents (1-3 were values previously determined to give linear
response on X-ray film). Gels 4 and 5 used a similar strategy, except that both
the 1 (lanes 3–5 and 9–11) and 2 (lanes 6–8 and 12–14) values of the 0%
control and two samples only were present on gel 4 and the 0% control and
duplicate 3 values of the same two samples were on gel 5 (lanes 3–5 and 9–
11). Two exposures to film were made from each blot and each film was
quantitated separately. Bands appearing on X-ray film were scanned using a
Personal Densitometer SI (Amersham Biosciences, Piscataway, NJ) and the
intensity of each band was expressed as a volume with the Spotfinder tool of
ImageQuant software. The band volume of each fraction was then normalized
to the volume of the 0% digitonin band within its virtual half. The two values at
a given cell equivalents (e.g., 1) for each % digitonin were then averaged.
Since each sample was analyzed at three cell equivalent values, 3 normalized
volume values were obtained for each % digitonin from each film exposure;
this yields 6 normalized values for each % digitonin for the two film exposures.
The same samples were subjected a second time to SDS-PAGE, Western
blotting, and band volume analysis to yield a second set of 6 normalized values
for each % digitonin. The entire experiment was repeated and the normalized
values for each % digitonin (n =24) were averaged.To validate this quantitation strategy, a single total mitochondrial extract
was used and loaded over a 3-fold concentration range for each of the four
mitochondrial markers. Electrophoresis, Western blotting, detection, and
quantitation were performed in duplicate exactly as described above yielding
12 data points at each ‘‘% digitonin’’ equivalent. Since the same sample was
present in all wells, the theoretical normalized volume would be 1 at each ‘‘%
digitonin’’ equivalent. For VDAC, results over the seven ‘‘% digitonin’’
equivalents showed an average relative volume of 1.03 (range 0.99–1.08)
with an average standard deviation (S.D.) of 0.08 (range 0.04–0.14). For
cytC, results over the seven ‘‘% digitonin’’ equivalents showed an average
relative volume of 1.15 (range 1.05–1.32) with an average S.D. of 0.18 (range
0.09–0.35). For COXIV, results over the seven ‘‘% digitonin’’ equivalents
showed an average relative volume of 1.21 (range 0.99–1.38) with an S.D. of
0.35 (range 0.13–0.67). For MnSOD, results over the seven ‘‘% digitonin’’
equivalents showed an average relative volume of 1.05 (range 1.01–1.12)
with an average S.D. of 0.13 (range 0.05–0.19). Thus, the quantitation
strategy was validated.
3. Results and discussion
3.1. Isolation of subcellular fractions from CCRF-CEM cells
A PNS from CCRF-CEM cells was fractionated into
cytosolic and mitochondrial fractions by differential centrifu-
gation. The fractions were assessed for purity and for
mitochondrial yield and integrity by assaying activities of
the cytosolic enzyme LDH and of the mitochondrial matrix
enzyme GDH (Table 1). GDH was assayed with and without
0.1% Triton X-100 detergent to assess latency [13] of the
activity, a measure of mitochondrial membrane integrity. The
cytosol contains virtually all the LDH activity and no GDH
activity indicating that the cytosol is free of mitochondrial
contamination. The mitochondrial fraction contains 75% of
the GDH activity found in the PNS showing a high yield of
mitochondria. Latency of GDH activity was 92% and 98%
for mitochondria and PNS, respectively, indicating high
mitochondrial integrity in both fractions. The low (2%
relative to PNS) LDH activity in the mitochondrial fraction
indicates very low cytosolic contamination of the mitochon-
drial pellet.
Fig. 1. Extraction of proteins from CCRF-CEM cell mitochondria by digitonin
treatment. Panel A. Quantitative Western blotting of the outer membrane
protein VDAC (D), intermembrane space protein cytC (˝), inner membrane
protein COX IV (>), matrix protein MnSOD (g), and mFPGS (?). Intact
mitochondria, prepared as described in Methods, were extracted with 0–0.7%
(w/v) digitonin in H-medium. Each sample was subjected to SDS-PAGE at
three concentrations over a three-fold range of cell equivalents in duplicate.
Two exposures to film were made from each blot and each film was quantitated
separately. Densitometric volume values obtained from both exposures of the
Western blots were normalized and combined as described in Methods. A
second SDS-PAGE was performed using the same samples and analyzed
similarly. The entire experiment was then repeated. The normalized data for
each percent digitonin from two experiments were pooled and are presented as
averageTS.D. (n =24). Symbols at each percent digitonin are offset to allow
error bars to be visible. Panel B. Representative Western blots for each protein
presented in Panel A. For COX IV and mFPGS, 1 is 3105 cell equivalents
and for MnSOD and VDAC, 1 is 5104 cell equivalents. Note that for
unknown reasons VDAC and cytC often appeared as doublets at about the
correct molecular weight; the doublets were quantitated as one band. Fig. 2. Freeze– thaw extraction from intact CCRF-CEM cell mitochondria of
soluble (MnSOD) and insoluble (VDAC) protein markers and of mFPGS. (A)
Quantitative distribution of VDAC, MnSOD and mFPGS in soluble and
membrane fractions. Intact mitochondria were prepared and subjected to
freeze– thaw extraction as described in Materials and methods. Soluble and
insoluble (membrane) fractions were prepared by ultracentrifugation. Samples
of an extract from intact mitochondria and soluble and insoluble fractions were
subjected to SDS-PAGE using a two-fold range of cell equivalents, each in
duplicate (n =4), employing the strategy described in Materials and methods.
After development of the Western blot with the appropriate antibody, two film
exposures were made and each was quantitated separately. The densitometric
volume from each fraction was normalized to the densitometric volume of
intact mitochondria at the same cell equivalents within its virtual half. The two
values at a given cell equivalents (e.g., 1 as defined in Fig. 1) were then
averaged. Since each sample was analyzed at two cell equivalent values this
yielded 4 normalized values for each fraction for the two film exposures. The
same samples were then re-analyzed by SDS-PAGE Western to yield
8 normalized values. A second freeze– thaw extraction was then performed
and analyzed in the same manner. The data from both extractions were pooled
and normalized data for each fraction (n =16) are presented as averageTS.D.
(B) Representative Western blots for each protein presented in Panel A.
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Exposure of intact mitochondria to increasing concentra-
tions of digitonin results in the extraction of proteins from the
four mitochondrial compartments in a successive manner
[8,18]. Using this method, the submitochondrial location of a
protein of interest is indicated by its release in parallel with a
protein marker of known location [8,18]. After extraction of the
CCRF-CEM mitochondrial fraction with digitonin (0–0.7%),
Western assays and densitometric analyses were used to
quantitate the retention of the mitochondrial proteins VDAC
(outer membrane; OM [19]), cytC (intermembrane space; IMS
[20]), COX IV (inner membrane; IM [21]) and MnSOD (matrix
[22]), as well as mFPGS, in the pellets from the different
digitonin concentrations (Fig. 1); all values were normalized toa 0% digitonin control. VDAC (OM) and cytC (IMS) were
most readily extracted by digitonin (Fig. 1). COXIV (IM) and
MnSOD (matrix) were more resistant to digitonin extraction
than VDAC and cytC and were extracted to similar extents
over the concentration range used. The extraction profile of
mFPGS closely parallels that of COXIV and MnSOD suggest-
ing that it is associated with the IM and/or the matrix.
3.3. Freeze–thaw fractionation of CCRF-CEM mitochondria.
The relationship between mFPGS and the IM and matrix was
examined further. Soluble (IMS+matrix) and insoluble mem-
brane (OM+IM) fractions of mitochondria can be prepared by
Fig. 3. Alkaline carbonate extraction from intact mitochondria of soluble/peri
pheral membrane proteins (MnSOD), integral membrane proteins (VDAC), and
of mFPGS. (A) Quantitative distribution of VDAC, MnSOD and mFPGS in
soluble and membrane fractions. Intact mitochondria were prepared and sub
jected to Na2CO3 or NaCl (control) extraction as described in Materials and
methods. A soluble/peripheral membrane protein fraction and an (insoluble
integral membrane protein fraction were prepared by ultracentrifugation from
each extract. Samples of an extract from intact mitochondria and the two fractions
from each extraction were subjected to SDS-PAGE using a two-fold range of cel
equivalents, each in duplicate (n =4), employing the strategy described in Mate
rials and methods. After development of the Western blot with the appropriate
antibody, two film exposures were made and each was quantitated separately as
described in the legend to Fig. 2. Second extractions were then performed and
analyzed in the same manner. The data from both extractions were pooled and
normalized data for each fraction (n =16) are presented as averageTS.D. (B
Representative Western blots for each protein presented in Panel A.
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freeze–thaw fractionation of CCRF-CEM mitochondria, virtu-
ally all of the VDAC, a representative membrane protein, is
present in the insoluble membrane fraction (Fig. 2). Release of
matrix-derived MnSOD, representative of soluble proteins, is
consistently incomplete ( 66% release), despite the use of two
sequential freeze–thaw procedures each of which contained 4
cycles. It is expected that if mFPGS is located in the matrix it
should solubilize to at least the same extent as MnSOD.
However, mFPGS distributes equally between the membrane
and soluble fractions, with the percentage in the membranes
being twice that observed for MnSOD. These data, together with
the digitonin extraction results (above), suggest that about 50%
of mFPGS is associated with the mitochondrial IM.
3.4. Sodium carbonate extraction of CCRF-CEM mitochondria
When mitochondria are subjected to alkaline carbonate (pH
11.5) extraction, peripheral membrane proteins are solubilized
while integral proteins remain in the (insoluble) membranes
[10]. Thus, alkaline carbonate extraction of CCRF-CEM
mitochondria was performed to investigate the nature of the
association of mFPGS with the IM (Fig. 3). As expected, the
OM integral protein VDAC was primarily recovered in the
membrane pellet following extraction while the soluble matrix
protein MnSOD was recovered in the soluble fraction. mFPGS
was distributed in both fractions with only a slightly greater
proportion in the soluble fraction. Normalized against intact
mitochondrial controls over 2 separate experiments, 79% of
mFPGS was in the soluble fraction, while 51% was
associated with the membrane fraction. These data, similar to
the freeze–thaw data (above), suggest a strong interaction of a
portion of mFPGS with the mitochondrial IM. A control
extraction using NaCl at the same measured ionic strength (Fig.
3) shows that the extraction is specific for the high pH
environment, as previously shown [10], and thus supports the
validity of the findings.
Digitonin and freeze–thaw fractionations of mitochondria
from CCRF-CEM leukemia cells suggest that human mFPGS
is associated with the IM and/or matrix subcompartments.
Furthermore, resistance of up to half of the mFPGS in whole
mitochondria to alkaline carbonate, but not high salt, extraction
suggests that its interaction with the IM is more similar to an
integral, than a peripheral, membrane protein. These data
appear to rule out simple ‘‘stickiness’’ of the protein, because
other sticky proteins are removed by high ionic strength [23]
and alkaline carbonate extraction [10]. This strong interaction
could be mediated by insertion into the IM of an amphipathic
coil formed by the mitochondrial signal sequence [24].
Monoamine oxidase B of the OM [25], d-alanine carboxy-
peptidase [26] and alpha-synuclein [27] are proteins suggested
to associate with membranes through an N-terminal amphi-
pathic coil. Although mitochondrial signal sequences are
generally removed by a processing peptidase after transloca-
tion, there are a number of examples where this motif is not
removed (e.g., rhodanese and 3-oxoacyl-CoA thiolase [24])





)the electrophoretic mobility of mFPGS is lower than that of
cFPGS [3], which is consistent with retention of all or part of
the 43-residue signal peptide in mature mFPGS. Further
investigation is required to determine the primary structure of
mature mFPGS.
The membrane location of a portion of mFPGS and the
presence of two forms of FPGS within mitochondria raise
issues regarding their physiological functions. Polyglutamyla-
tion is required to retain folates within the cytosol or mito-
chondria following transport [1,28]. Since the folate pool in
mitochondria is likely located in the matrix [4,29], localization
of mFPGS either in the matrix or the inner leaflet of the IM
would provide FPGS activity to the matrix. An inner mem-
brane location for mFPGS could allow transport of folates by
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coupled with their polyglutamylation by decreasing the
diffusion path between these two proteins, thus leading to
greater efficiency in the overall process. If the two proteins
actually form a two-enzyme complex (or are apposed in a
multienzyme complex), direct transfer of folate from the
mitochondrial folate transport protein to membrane-bound
mFPGS would further increase efficiency. This latter possibil-
ity will be explored in chemical cross-linking studies.
Membrane-bound and matrix mFPGS isoforms may also
perform different functions within mitochondria. This could
occur if, for example, the two forms are differentially processed
(yielding slight differences in sequence) or as a result of
posttranslational modification. Differential processing has been
shown to affect the kinetic properties of multiple forms of
mitochondrial uracil-DNA glycosylase transcribed from a
single gene [31]. One possibility for the difference in function
is that the membrane-bound form may add only the first g-
glutamyl residue following transport to form the diglutamate;
diglutamates are retained at least 10-fold better than are mono-
glutamates [32]. The diglutamyl folate could then be released
into the matrix where the matrix isoform completes the
polyglutamylation. The kinetic properties of the two mFPGS
forms are also currently under investigation.
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